Propanc Biopharma released FY2025 Q2 earnings on February 14, 2025 (EST), actual revenue USD 0, actual EPS USD 0

Brief Summary

Propanc Biopharma reported zero revenue and a net loss of $430,183 for the second quarter of fiscal year 2025, maintaining an earnings per share (EPS) of 0.

Impact of The News

Financial Performance Overview